Literature DB >> 21427580

Pathophysiology of rheumatoid arthritis.

Faye A H Cooles1, John D Isaacs.   

Abstract

PURPOSE OF REVIEW: To provide a summary of recent advances in the pathophysiology of rheumatoid arthritis. RECENT
FINDINGS: Highlights include further elucidation of the relationship between the shared epitope, smoking and anticitrullinated protein/peptide antibody generation, including identification of putative citrullinated auto-antigens; and a hypothesis linking citrullinating oral bacteria and anticitrullinated protein/peptide antibody generation. Important work on signalling within regulatory T cells has identified sequestration of protein kinase C theta away from the immune synapse as critical for suppressive activity; TNFα exposure interferes with protein kinase C theta compartmentalisation, explaining its inhibition of regulatory T cell function. Platelet microparticles have emerged as important pro-inflammatory mediators via their stimulatory effects on fibroblast-like synoviocytes. The mechanisms by which fibroblast-like synoviocyte invade are becoming elucidated, and recent work suggests the capacity of these cells to migrate from joint to joint, potentially explaining the evolution of clinical rheumatoid arthritis.
SUMMARY: Our knowledge of rheumatoid arthritis pathogenesis continues to expand. The last year has seen some key findings, including the identification of novel, potentially tractable targets for further therapeutic research.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21427580     DOI: 10.1097/BOR.0b013e32834518a3

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  56 in total

1.  The fluence effects of low-level laser therapy on inflammation, fibroblast-like synoviocytes, and synovial apoptosis in rats with adjuvant-induced arthritis.

Authors:  Yueh-Ling Hsieh; Yu-Jung Cheng; Fang-Chuen Huang; Chen-Chia Yang
Journal:  Photomed Laser Surg       Date:  2014-12       Impact factor: 2.796

Review 2.  Environmental and gene-environment interactions and risk of rheumatoid arthritis.

Authors:  Elizabeth W Karlson; Kevin Deane
Journal:  Rheum Dis Clin North Am       Date:  2012-05-30       Impact factor: 2.670

3.  Molecular dynamics and integrated pharmacophore-based identification of dual [Formula: see text] inhibitors.

Authors:  Maninder Kaur; Pankaj Kumar Singh; Manjinder Singh; Renu Bahadur; Om Silakari
Journal:  Mol Divers       Date:  2017-11-14       Impact factor: 2.943

4.  KCa1.1 inhibition attenuates fibroblast-like synoviocyte invasiveness and ameliorates disease in rat models of rheumatoid arthritis.

Authors:  Mark R Tanner; Xueyou Hu; Redwan Huq; Rajeev B Tajhya; Liang Sun; Fatima S Khan; Teresina Laragione; Frank T Horrigan; Pércio S Gulko; Christine Beeton
Journal:  Arthritis Rheumatol       Date:  2015-01       Impact factor: 10.995

5.  Innate immunity sensors participating in pathophysiology of joint diseases: a brief overview.

Authors:  Jiri Gallo; Milan Raska; Yrjo T Konttinen; Christophe Nich; Stuart B Goodman
Journal:  J Long Term Eff Med Implants       Date:  2014

6.  Increased miR-223 expression in T cells from patients with rheumatoid arthritis leads to decreased insulin-like growth factor-1-mediated interleukin-10 production.

Authors:  M-C Lu; C-L Yu; H-C Chen; H-C Yu; H-B Huang; N-S Lai
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

7.  Methotrexate affects HMGB1 expression in rheumatoid arthritis, and the downregulation of HMGB1 prevents rheumatoid arthritis progression.

Authors:  Yuan-Bo Li; Peng Xu; Ke Xu; Yong-Song Cai; Meng-Yao Sun; Le Yang; Jian Sun; She-Min Lu
Journal:  Mol Cell Biochem       Date:  2016-08-13       Impact factor: 3.396

8.  Increased expression of long noncoding RNAs LOC100652951 and LOC100506036 in T cells from patients with rheumatoid arthritis facilitates the inflammatory responses.

Authors:  Ming-Chi Lu; Hui-Chun Yu; Chia-Li Yu; Hsien-Bin Huang; Malcolm Koo; Chien-Hsueh Tung; Ning-Sheng Lai
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

9.  Superior performance of the CCP3.1 test compared to CCP2 and MCV in the rheumatoid factor-negative RA population.

Authors:  Zoltán Szekanecz; Zoltán Szabó; Margit Zeher; Lilla Soós; Katalin Dankó; Ildikó Horváth; Gabriella Lakos
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

Review 10.  Genetics of rheumatoid arthritis - a comprehensive review.

Authors:  Júlia Kurkó; Timea Besenyei; Judit Laki; Tibor T Glant; Katalin Mikecz; Zoltán Szekanecz
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.